Spanning the Seed to Series A Valley of Death – Strategies for Scaling Canadian Biotechs

​Join us to discuss how to avoid the biotech valley of death and fundraise successfully!

​Explore strategies for navigating the transition from Seed to Series A funding, avoiding common startup pitfalls, and positioning biotech companies for long-term growth, partnerships, and investment. Hear from the biotech and investor perspective in the US and Canada.

​BioLabs U of T Innovation Program:

​This is the second event in the BioLabs University of Toronto Networking Event Series, a program designed to strengthen Toronto's life sciences ecosystem by connecting founders, investors, researchers, and industry leaders from across North America.

​Panelists

​Parimal Nathwani, Managing Partner, Life Sciences Fund, BDC

​Daniel Durocher​, Co-Founder, Induxion Therapeutics

​Jennifer Griffin​, Partner, Strategy & Investor Relations, Mission BioCapital

​Cory Sago​, CEO/Founder, Amplitude Therapeutics

​Moderated by Jennifer Fraser​, Director of Innovation, University of Toronto

​What to Expect:

​5:00–5:30 PM - Registration & Networking

​5:30–6:30 PM - Panel Discussion

​6:30–8:00 PM - Networking Reception

​8:00 PM - Event Conclusion

​Space is limited, reserve your spot today!

​Date & Time

​October 22, 2026 | 5:00–8:00 PM EDT

​Location

​BioLabs University of Toronto
661 University Ave., Suite 1300
Toronto, Ontario M5G 1M1